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Abstract
Background: Oxidative stress is known to be a factor in various diseases. In this study, we investigated whether
physical and psychological symptoms of menopause, cardiovascular parameters, body composition, and lifestyle
factors are associated with oxidative stress in middle-aged women.
Methods: This cross-sectional study used baseline data collected in a previous study that examined the effects of
a dietary supplement on a variety of health parameters in 95 women aged 40 to 60 years. Participants had been
assessed for age, menopausal status, body composition, cardiovascular parameters, physical and psychological
symptoms of menopause, and lifestyle factors. Urinary 8-hydroxy-2′-deoxyguanosine (8-OHdG) level, an oxidative
stress marker, had also been measured. Dichotomizing 8-OHdG levels as low (≤25 ng/mg creatinine) and high
(>25 ng/mg creatinine), we sought to identify the health parameters that are associated with high 8-OHdG level.
Results: Women with a high 8-OHdG level had lower body weight, lower body mass index, lower body fat mass,
higher body temperature, scored higher for both anxiety and depression on the Hospital Anxiety and Depression
Scale (HADS), and consumed more alcohol. Multiple logistic regression analysis revealed that the HADS-depression
subscale (HADS-D) score was the sole independent contributor to high 8-OHdG level (adjusted odds ratio, 1.23 per
point increase in HADS-D score; 95 % confidence interval, 1.06–1.45).
Conclusion: Depressive symptom score was shown to be independently associated with high 8-OHdG level in
middle-aged women, suggesting a link between mood disorder and oxidative stress.
Trial registration: UMIN-CTR UMIN000009353.
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Background
Health promotion for middle-aged women is gaining at-
tention due to the various health care issues raised with
the advent of an aging society. Women in this age group
are not only bothered by menopausal symptoms, such as
hot flashes, night sweats, vaginal dryness, anxiety, de-
pression, and insomnia, but are also at increased risk for
cardiovascular disease (CVD), central obesity, hyperten-
sion, dyslipidemia, and diabetes [1–4].
Oxygen is vital for all aerobic organisms. During aer-
obic metabolism, oxygen is reduced into water, and in
the process, reactive oxygen species (ROS), such as super-
oxide anion, hydrogen peroxide, hydroxyl radical, and
singlet oxygen, are generated [5]. ROS are highly reactive
molecules that chemically change the structures of pro-
teins, lipids, and nucleic acids, and cause cell and tissue
damage [6, 7]. Organisms have an antioxidant reaction to
protect themselves against ROS through detoxification
mechanisms mediated by antioxidants and antioxidant en-
zymes [5]. Excessive ROS production or antioxidant defi-
ciency leads to damage of aerobic organisms; imbalance
between oxidants and antioxidants in favor of the former
is referred to as oxidative stress [8, 9].
First introduced by Sies in 1985 [10], oxidative stress has
been found to contribute to the development of various
diseases, including cancer [11], atherosclerosis [12, 13],
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myocardial infarction [13], Parkinson’s disease [14], Alzhei-
mer’s disease [15], inflammatory airway diseases [16], and
age-related illness [17]. The severity of oxidative stress can
be quantified by measuring the concentration of specific
biomarkers, one of which is 8-hydroxy-2′-deoxyguano-
sine (8-OHdG), an index of oxidatively damaged DNA
[18, 19]. Recently, a novel automatic analyzer for com-
petitive immunochromatography was developed, mak-
ing measurement of urinary 8-OHdG level much
quicker and easier than before.
The aim of this study was to investigate whether physical
and psychological symptoms of menopause, cardiovascular
parameters, body composition, and lifestyle factors are as-
sociated with oxidative stress in middle-aged women using
urinary 8-OHdG level as a marker.
Methods
Study population
We performed a cross-sectional analysis using the base-
line data of a previous study [20] conducted at the
Menopause Clinic of Tokyo Medical and Dental Univer-
sity to examine the effects of a dietary supplement on a
variety of health parameters in 95 Japanese women aged
40 to 60 years. The participants were recruited through
advertisements posted in our hospital and the patients’
own social network. Women who scored positive for at
least one symptom item on the Menopausal Health-
Related Quality of Life (MHR-QOL) Questionnaire were
eligible for the study, and those who were receiving meno-
pausal hormone therapy were excluded. Collected data in-
cluded age, menopausal status, lifestyle factors, physical
and psychological symptoms of menopause, body com-
position, cardiovascular parameters, and urinary 8-OHdG
level. The study protocol was reviewed and approved by
the Medical Research Ethics Committee of Tokyo Medical
and Dental University (No. 1359), and written informed
consent was obtained from all participants. The study was
conducted in accordance with the Declaration of Helsinki.
Regarding menopausal status, participants were classi-
fied as follows: premenopausal (regular menstrual cycles in
the past 3 months), perimenopausal (a menstrual period
within the past 12 months but a missed period or irregular
cycles in the past 3 months), postmenopausal (no men-
strual period in the past 12 months), or surgically induced
menopause (hysterectomy).
Body composition and cardiovascular parameters
Body composition, including height, weight, body mass
index, fat mass, and muscle mass, was assessed using a
body composition analyzer (MC190-EM; Tanita, Tokyo,
Japan). Cardiovascular parameters, including systolic and
diastolic blood pressure, heart rate, and arterial stiffness
index (cardio-ankle vascular index), were measured using
a vascular screening system (VS-1000; Fukuda Denshi Co.,
Tokyo, Japan).
Menopausal symptoms
Menopausal symptoms were evaluated using the MHR-
QOL Questionnaire, Hospital Anxiety and Depression
Scale (HADS), and Athens Insomnia Scale (AIS). The
MHR-QOL Questionnaire, developed and validated in our
clinic, is a modification of the Women’s Health Question-
naire [21, 22] that contains 38 items scored on a four-point
or binary scale covering four major domains (physical
health, mental health, life satisfaction, and social involve-
ment) of a woman’s health during menopause. The phys-
ical health domain consists of nine items that assess
somatic (sickness/nausea, dizzy spells, tingling/numbness,
backache/pain in limbs, tiredness, and headaches), urinary
(urinary frequency), and vasomotor (hot flashes and night
sweats) symptoms. The mental health domain consists
of 12 items that assess symptoms of loss of interest in
things, lack of enjoyment, low energy, depressed mood,
poor memory, difficulty in concentration, frightened/
panicky feelings, feeling tense/wound up, dissatisfaction
with sexual relationship, difficulty in initiating sleep,
nonrestorative sleep, and low self-esteem. Higher scores
on the items indicate worse physical function (0 points,
none to once per month; 1 point, 1–2 times per week;
2 points, 3–4 times per week; 3 points, almost every
day). The total scores of the physical and mental health
domains were designated the “physical symptom score”
and “psychological symptom score” respectively. The
HADS, developed by Zigmond and Snaith [23], is a reli-
able instrument for screening clinically significant anxiety
and depressive symptoms in women visiting a general
medicine clinic; it has been translated into Japanese by
Kitamura et al. [24]. The AIS was developed as a brief and
easy-to-administer self-assessment questionnaire for de-
termining the severity of insomnia defined according to
the International Classification of Diseases 10th Revision.
The internal consistency and test-retest reliability of the
AIS have been confirmed previously [25]. Detailed infor-
mation about the MHR-QOL Questionnaire, HADS, and
AIS is provided elsewhere [20].
Oxidative stress
Urinary 8-OHdG level was measured by competitive
immunochromatography using a novel automatic analyzer
(ICR-001; Techno Medica, Tokyo, Japan). The participants
produced urine samples at our clinic, which were instantly
centrifuged at 3000 rpm for 5 min. After dilution twice
with distilled water, 8-OHdG (ng) and creatinine (mg)
concentration were measured to calculate 8-OHdG level
corrected by creatinine (ng/mg creatinine). In the present
study, we dichotomized 8-OHdG levels as low (≤25 ng/
mg creatinine) and high (>25 ng/mg creatinine) according
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to previous research that analyzed 140 samples collected
from healthy workers at a coke oven plant [26]. In that
study, the mean ± SD value measured by using enzyme-
linked immunosorbent assay (ELISA) was 14.9 ± 9.3 ng/
mg creatinine in subjects who were employed in the coke
operation area and 14.7 ± 12.8 ng/mg creatinine in sub-
jects who worked only in an administrative area. Based on
the mean + 1SD value in that study, we arbitrarily set our
cut-off index at 25 ng/mg creatinine.
Statistical analyses
First, all variables were compared between the two 8-
OHdG level groups using univariate analysis (unpaired t
test, chi-square test, and Mann–Whitney U test). Then,
variables emerging with possible prognostic value for high
8-OHdG level (P < 0.20) were entered into stepwise mul-
tiple logistic regression analysis. Variables that remained
significant (P < 0.05) were retained in the final multivari-
able model and were considered to be associated with oxi-
dative stress in middle-aged women. All statistical analyses
were performed using SAS version 9.2 (SAS Institute, Cary,
NC, USA).
Results
The 95 participants were divided into two groups ac-
cording to urinary 8-OHdG level: 59 women had a low
level (≤25 ng/mg creatinine) and 36 had a high level
(>25 ng/mg creatinine).
The background characteristics of the women are
shown by group in Table 1. First, we examined differences
between groups using univariate analysis to select vari-
ables with possible prognostic value for high 8-OHdG
level. Mean age and menopausal status were similar be-
tween groups. Women with a high 8-OHdG level tended
to have lower body weight (51.0 ± 8.3 kg vs. 53.5 ±
6.5 kg, P = 0.111), lower body mass index (20.6 ± 3.4 kg/
m2 vs. 21.9 ± 2.5 kg/m2, P = 0.048), lower body fat mass
(12.9 ± 6.3 kg vs. 15.1 ± 4.8 kg, P = 0.062), higher body
temperature (36.4 ± 0.4 °C vs. 36.2 ± 0.5 °C, P = 0.123),
scored higher for anxiety (6.0 ± 3.4 vs. 4.9 ± 2.6, P =
0.100) and depression (5.3 ± 3.6 vs. 3.5 ± 2.3, P = 0.018)
on the HADS, and scored higher on the MHR-QOL
psychological symptom score (8.2 ± 8.9 vs. 4.6 ± 4.7, P =
0.054). They also consumed more alcohol (proportion
of women who drank daily, 22.2 % vs. 11.9 %, P = 0.196)
(Table 1).
Next, these variables were entered into multivariate
analysis to identify the factors that contribute independ-
ently to high 8-OHdG level, except for MHR-QOL psy-
chological symptom scores, as they were represented by
HADS-anxiety and depression scores. Stepwise multiple
logistic regression analysis revealed that, among these
factors, HADS-depression subscale (HADS-D) score was
the sole independent contributor to high 8-OHdG level
(adjusted odds ratio, 1.23 per point increase in HADS-D
score; 95 % confidence interval, 1.06–1.45) (Table 2).
Considering the multicollinearity of the three body com-
position variables, we analyzed the data putting each of
them into multiple logistic regression analysis, only to
find HADS-depression score was still the sole independ-
ent contributor to high 8-OHdG level (data not shown).






(n = 59) (n = 36)
Age, y 49.5 ± 5.1 50.0 ± 5.0 0.637a
Menopausal status, %
Premenopausal 42.4 38.9 0.771b
Perimenopausal 22.0 22.2
Postmenopausal 25.4 33.3
Surgically induced menopause 10.2 5.6
Body composition
Height, cm 156.4 ± 5.3 157.2 ± 4.6 0.434a
Weight, kg 53.5 ± 6.5 51.0 ± 8.3 0.111a
Body mass index, kg/cm2 21.9 ± 2.5 20.6 ± 3.4 0.048a
Body fat mass, kg 15.1 ± 4.8 12.9 ± 6.3 0.062a
Muscle mass, kg 36.2 ± 2.5 35.9 ± 2.7 0.630a
Waist:hip ratio, % 85.6 ± 6.9 85.1 ± 8.4 0.760a
Body temperature, °C 36.2 ± 0.5 36.4 ± 0.4 0.123a
Cardiovascular parameters
Systolic blood pressure, mmHg 122.5 ± 14.6 119.4 ± 15.5 0.317a
Diastolic blood pressure,
mmHg
78.6 ± 10.3 76.9 ± 10.3 0.433a
Heart rate, beats/min 63.3 ± 7.5 64.9 ± 9.8 0.382a
CAVI 7.16 ± 0.68 7.29 ± 0.83 0.405a
MHR-QOL physical symptom
score
5.58 ± 3.41 5.81 ± 3.85 0.865c
MHR-QOL psychological
symptom score
4.63 ± 4.71 8.17 ± 8.85 0.054c
HADS-anxiety subscale score 4.86 ± 2.62 6.03 ± 3.36 0.100c
HADS-depression subscale
score
3.48 ± 2.30 5.25 ± 3.63 0.018c
AIS score 4.09 ± 2.99 3.75 ± 3.11 0.524c
Lifestyle factors, %
Working 89.8 83.3 0.362c
Exercising regularly 45.8 47.2 1.000c








Values are presented as mean ± SD unless otherwise indicated
AIS Athens insomnia scale, CAVI cardio-ankle vascular index, HADS hospital
anxiety and depression scale, MHR-QOL menopausal health-related quality of life
aAccording to the unpaired t test, bAccording to the chi-square test,
cAccording to the Mann–Whitney U test
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Discussion
In this cross-sectional analysis of 95 middle-aged women,
we investigated the associations between various health
parameters and oxidative stress and revealed that the de-
pressive symptom score was independently associated
with high urinary 8-OHdG level, suggesting a link be-
tween mood disorder and oxidative stress. The result that
all the variables except depressive symptom score did
not remain in the final model suggests that their associ-
ation with oxidative stress was cofounded with depres-
sive symptoms.
In order to evaluate the state of oxidative stress,
various biomarkers have been developed to assess the
damage induced by ROS or the defense provided by
antioxidants. Well-known biomarkers include malon-
dialdehyde, hexanoyl-lysine, isoprostanes, and protein
carbonyls, which are produced through oxidative dam-
age of lipids and proteins, while antioxidant enzymes
include superoxide dismutase, catalase, glutathione
peroxidase, and glutathione [8, 27].
8-OHdG, deoxyguanosine hydroxylated at the C-8 pos-
ition, is a biomarker of oxidative DNA damage [18, 19].
First reported by Kasai et al. in 1984 [28], it has become
one of the most widely used markers of oxidative stress.
Chemical carcinogens, tumor-promoting agents, and life-
style factors, such as smoking and drinking, have been re-
ported to increase 8-OHdG level in human organ and
leukocyte DNA [18, 19, 29]. Urinary 8-OHdG level can
be measured by cumbersome methods, such as high-
performance liquid chromatography with electrochemical
detection, gas chromatography with mass spectrometry,
liquid chromatography with tandem mass spectrometry,
and ELISA [30]. A recently developed automatic analyzer
for competitive immunochromatography, ICR-001, has
made measurement of urinary 8-OHdG level much
quicker and easier than before. Thus far, three research
papers have been published using the ICR-001 system
to measure urinary 8-OHdG levels [31–33].
For middle-aged women, depression is an important
health care issue. Although, the main predictor of de-
pression during the perimenopausal period is the symp-
tom before menopause in addition to other psychosocial
factors, several studies have suggested that new-onset
depressive symptoms increase during the transition to
menopause [34]. One study also revealed that fluctua-
tions rather than absolute levels in estradiol and
follicle-stimulating hormone in postmenopausal women
are associated with increased risk of depressive symp-
toms [35]. A meta-analysis of 23 studies was recently per-
formed to evaluate the association between depression
and oxidative stress and/or antioxidant status in general
[36]. Depressive symptoms were found to be associated
with increased oxidative stress and lower antioxidant sta-
tus; however, the measures of oxidative stress and antioxi-
dant status, the assessment of depressive symptoms, and
the sample populations were heterogeneous. Some studies
using peripheral leukocytes [37], sera [6, 38, 39] or urine
samples [40, 41] have revealed an association between de-
pressive symptoms and high 8-OHdG level. Regarding the
two studies using urine samples, one investigated the asso-
ciation between 8-OHdG level with major depression and
myalgic encephalomyelitis/chronic fatigue syndrome [40],
while the other assessed the urinary excretion of the oxi-
dative stress marker throughout the menstrual cycle in
young women [41]. The present study was the first to use
a novel automatic analyzer of urinary 8-OHdG level to in-
vestigate the association between depressive symptoms
and oxidative stress in middle-aged women.
Although the mechanisms linking depressive symptoms
to oxidative stress remain unknown, some possibilities are
suggested. First, depressed women may have lifestyles or
behaviors that increase oxidative stress. Second, depressive
symptoms may lead to increased production of ROS, which
would contribute to oxidative stress. Third, depressive
symptoms may weaken the antioxidant defense system.
Fourth, the fluctuations in estradiol and follicle-stimulating
hormone, which are suggested to be associated with de-
pressive symptoms [35], may also increase oxidative stress.
Finally, high oxidative stress may lower serotonin and nor-
epinephrine levels, which would lead to depressive symp-
toms. In the present study, we negated the possibility that
other factors such as age, menopausal status, lifestyle fac-
tors (including working, exercise, smoking, and alcohol
consumption), physical and psychological symptoms of
Table 2 Factors associated with high urinary 8-OHdG level (>25 ng/mg creatinine) according to multiple logistic regression analysis
Crude OR (95 % CI) P value Adjusted OR (95 % CI) P value
Weight 0.95 (0.89–1.01) 0.110
Body mass index 0.84 (0.70–0.98) 0.038
Body fat mass 0.92 (0.84–1.00) 0.056
Body temperature 2.16 (0.84–6.13) 0.126
HADS-anxiety subscale score 1.14 (0.99–1.32) 0.083
HADS-depression subscale score 1.23 (1.06–1.45) 0.011 1.23 (1.06–1.45) 0.011
Daily alcohol consumption 2.20 (0.72–6.72) 0.166
CI confidence interval, HADS hospital anxiety and depression scale, OR odds ratio
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menopause, body composition, and cardiovascular parame-
ters were confounding. Depressive symptoms and oxidative
stress may affect bidirectionally; thus, further research is re-
quired to clarify the underlying mechanisms that evaluates
several oxidative stress biomarkers, including resultant oxi-
dative products and antioxidant enzymes simultaneously,
as well as estradiol, follicle-stimulating hormone, serotonin,
and norepinephrine levels.
The present study has some limitations: (1) the number
of participants was relatively small, and (2) all participants
were relatively healthy women. In order to determine the
association between oxidative stress and depressive
symptoms, further studies with a larger sample includ-
ing middle-aged women with more severe depressive
symptoms are warranted.
Conclusion
Depressive symptom score was shown to be independ-
ently associated with high 8-OHdG level in middle-aged
women, suggesting a link between mood disorder and
oxidative stress in this population.
Ethics approval and consent to participate
The study protocol was reviewed and approved by the
Medical Research Ethics Committee of Tokyo Medical
and Dental University (No. 1359), and written informed
consent was obtained from all participants. The study




Availability of data and materials
The datasets are available upon reasonable request.
Abbreviations
AIS: Athens insomnia scale; CVD: cardiovascular disease; ELISA: enzyme-linked
immunosorbent assay; HADS: hospital anxiety and depression scale; MHR-
QOL: menopausal health-related quality of life; ROS: reactive oxygen species;
8-OHdG: 8-hydroxy-2′-deoxyguanosine.
Competing interests
The authors declare that they have no competing interests.
Authors’ contributions
AH and MT conceptualized and designed the study and collected and
analyzed the data. TK participated in the design of the study and the project
supervision. MA, YO, and KK participated in the data collection. AH drafted
the manuscript. All authors have read and approved the final manuscript.
Acknowledgements
This research was supported by Kikkoman Corporation.
Funding
MT received an unrestricted research grant from Kikkoman Corporation.
Author details
1Department of Obstetrics and Gynecology, Tokyo Medical and Dental
University, Yushima 1-5-45, Bunkyo, Tokyo 113-8510, Japan. 2Department of
Women’s Health, Tokyo Medical and Dental University, Yushima 1-5-45,
Bunkyo, Tokyo 113-8510, Japan.
Received: 8 February 2016 Accepted: 18 April 2016
References
1. Carr MC. The emergence of the metabolic syndrome with menopause.
J Clin Endocrinol Metab. 2003;88:2404–11.
2. Rosano GM, Vitale C, Tulli A. Managing cardiovascular risk in menopausal
women. Climacteric. 2006;9 Suppl 1:19–27.
3. Collins P, Rosano G, Casey C, Daly C, Gambacciani M, Hadji P, et al.
Management of cardiovascular risk in the peri-menopausal woman: a
consensus statement of European cardiologists and gynaecologists.
Eur Heart J. 2007;28:2028–40.
4. Lizcano F, Guzmán G. Estrogen Deficiency and the Origin of Obesity during
Menopause. Biomed Res Int. 2014;2014:757461. doi:10.1155/2014/757461.
5. Kalyanaraman B. Teaching the basics of redox biology to medical and
graduate students: Oxidants, antioxidants and disease mechanisms. Redox
Biol. 2013;1:244–57.
6. Wei YC, Zhou FL, He DL, Bai JR, Hui LY, Wang XY, et al. The level of
oxidative stress and the expression of genes involved in DNA-damage
signaling pathways in depressive patients with colorectal carcinoma.
J Psychosom Res. 2009;66:259–66.
7. Murphy MP. How mitochondria produce reactive oxygen species. Biochem
J. 2009;417:1–13.
8. Poljsak B, Šuput D, Milisav I. Achieving the balance between ROS and
antioxidants: when to use the synthetic antioxidants. Oxid Med Cell Longev.
2013;2013:956792. doi:10.1155/2013/956792.
9. Higami Y, Shimokawa I. Apoptosis in the aging process. Cell Tissue Res.
2000;301:125–32.
10. Sies H, Cadenas E. Oxidative stress: damage to intact cells and organs.
Philos Trans R Soc Lond B Biol Sci. 1985;311:617–31.
11. Halliwell B. Oxidative stress and cancer: have we moved forward? Biochem
J. 2007;401:1–11.
12. Schleicher E, Friess U. Oxidative stress, AGE, and atherosclerosis. Kidney Int
Suppl. 2007;106:S17–26.
13. Chen YR, Zweier JL. Cardiac mitochondria and reactive oxygen species
generation. Circ Res. 2014;114:524–37.
14. Dias V, Junn E, Mouradian MM. The role of oxidative stress in Parkinson’s
disease. J Parkinsons Dis. 2013;3:461–91.
15. Choi DY, Lee YJ, Hong JT, Lee HJ. Antioxidant properties of natural
polyphenols and their therapeutic potentials for Alzheimer’s disease. Brain
Res Bull. 2012;87:144–53.
16. Wood LG, Wark PA, Garg ML. Antioxidant and anti-inflammatory effects of
resveratrol in airway disease. Antioxid Redox Signal. 2010;13:1535–48.
17. Yan LJ. Positive oxidative stress in aging and aging-related disease
tolerance. Redox Biol. 2014;2C:165–9.
18. Kasai H. Analysis of a form of oxidative DNA damage, 8-hydroxy-2′-
deoxyguanosine, as a marker of cellular oxidative stress during
carcinogenesis. Mutat Res. 1997;387:147–63.
19. Wu LL, Chiou CC, Chang PY, Wu JT. Urinary 8-OHdG: a marker of oxidative
stress to DNA and a risk factor for cancer, atherosclerosis and diabetics.
Clin Chim Acta. 2004;339:1–9.
20. Terauchi M, Horiguchi N, Kajiyama A, Akiyoshi M, Owa Y, Kato K, et al.
Effects of grape seed proanthocyanidin extract on menopausal symptoms,
body composition, and cardiovascular parameters in middle-aged women:
a randomized, double-blind, placebo-controlled pilot study. Menopause.
2014;21:990–6.
21. Hunter M, Battersby R, Whitehead M. Relationships between psychological
symptoms, somatic complaints and menopausal status. Maturitas. 1986;8:
217–28.
22. Hunter M. The south-east England longitudinal study of the climacteric and
postmenopause. Maturitas. 1992;14:117–26.
23. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta
Psychiatr Scand. 1983;67:361–70.
24. Zigmond AS, Snaith RP, Kitamura T. The Hospital Anxiety and Depression
Scale (in Japanese). Seisinka-Sindangaku. 1993;4:371–2.
25. Soldatos CR, Dikeos DG, Paparrigopoulos TJ. Athens Insomnia Scale:
validation of an instrument based on ICD-10 criteria. J Psychosom Res.
2000;48:555–60.
Hirose et al. BioPsychoSocial Medicine  (2016) 10:12 Page 5 of 6
26. Hu CW, Wu MT, Chao MR, Pan CH, Wang CJ, Swenberg JA, et al.
Comparison of analyses of urinary 8-hydroxy-2′-deoxyguanosine by isotope-
dilution liquid chromatography with electrospray tandem mass
spectrometry and by enzyme-linked immunosorbent assay. Rapid Commun
Mass Spectrom. 2004;18:505–10.
27. Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A. Biomarkers of
oxidative damage in human disease. Clin Chem. 2006;52:601–23.
28. Kasai H, Hayami H, Yamaizumi Z, Saitô H, Nishimura S. Detection and
identification of mutagens and carcinogens as their adducts with guanosine
derivatives. Nucleic Acids Res. 1984;12:2127–36.
29. Mei S, Yao Q, Wu C, Xu G. Determination of urinary 8-hydroxy-2′-
deoxyguanosine by two approaches-capillary electrophoresis and GC/MS:
an assay for in vivo oxidative DNA damage in cancer patients. J Chromatogr
B Analyt Technol Biomed Life Sci. 2005;827:83–7.
30. Pilger A, Rüdiger HW. 8-Hydroxy-2′-deoxyguanosine as a marker of oxidative
DNA damage related to occupational and environmental exposures.
Int Arch Occup Environ Health. 2006;80:1–15.
31. Masugata H, Senda S, Murao K, Inukai M, Himoto T, Hosomi N, et al.
Association between urinary 8-hydroxydeoxyguanosine, an indicator of
oxidative stress, and the cardio-ankle vascular index in hypertensive
patients. J Atheroscler Thromb. 2012;19:747–55.
32. Masugata H, Senda S, Inukai M, Himoto T, Imachi H, Murao K, et al.
Association between oxidative stress assessed by urinary 8-
hydroxydeoxyguanosine and the cardiac function in hypertensive patients
without overt heart disease. Clin Exp Hypertens. 2013;35:308–12.
33. Kaneko K, Kimata T, Tsuji S, Ohashi A, Imai Y, Sudo H, et al. Measurement of
urinary 8-oxo-7,8-dihydro-2-deoxyguanosine in a novel point-of-care testing
device to assess oxidative stress in children. Clin Chim Acta. 2012;413:1822–6.
34. Llaneza P, García-Portilla MP, Llaneza-Suárez D, Armott B, Pérez-López FR.
Depressive disorders and the menopause transition. Maturitas. 2012;71:120–30.
35. Ryan J, Burger HG, Szoeke C, Lehert P, Ancelin ML, Henderson VW,
et al. A prospective study of the association between endogenous
hormones and depressive symptoms in postmenopausal women.
Menopause. 2009;16:509–17.
36. Palta P, Samuel LJ, Miller ER, Szanton SL. Depression and oxidative stress:
results from a meta-analysis of observational studies. Psychosom Med.
2014;76:12–9.
37. Irie M, Miyata M, Kasai H. Depression and possible cancer risk due to
oxidative DNA damage. J Psychiatr Res. 2005;39:553–60.
38. Forlenza MJ, Miller GE. Increased serum levels of 8-hydroxy-2′-
deoxyguanosine in clinical depression. Psychosom Med. 2006;68:1–7.
39. Kupper N, Gidron Y, Winter J, Denollet J. Association between type D
personality, depression, and oxidative stress in patients with chronic heart
failure. Psychosom Med. 2009;71:973–80.
40. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E.
Increased 8-hydroxy-deoxyguanosine, a marker of oxidative damage to
DNA, in major depression and myalgic encephalomyelitis/chronic fatigue
syndrome. Neuro Endocrinol Lett. 2009;30:715–22.
41. Iida T, Inoue K, Ito Y, Ishikawa H, Kagiono M, Teradaira R, et al. Comparison
of urinary levels of 8-hydroxy-2′-deoxyguanosine between young females
with and without depressive symptoms during different menstrual phases.
Acta Med Okayama. 2015;69:45–50.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Hirose et al. BioPsychoSocial Medicine  (2016) 10:12 Page 6 of 6
